Cargando…
Retinoic acid inducible gene I Activates innate antiviral response against human parainfluenza virus type 3
Human parainfluenza virus type 3 (HPIV3) is a respiratory paramyxovirus that infects lung epithelial cells to cause high morbidity among infants and children. To date, no effective vaccine or antiviral therapy exists for HPIV3 and therefore, it is important to study innate immune antiviral response...
Autores principales: | Sabbah, Ahmed, Bose, Santanu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2783035/ https://www.ncbi.nlm.nih.gov/pubmed/19922606 http://dx.doi.org/10.1186/1743-422X-6-200 |
Ejemplares similares
-
Activation of innate immune antiviral response by NOD2
por: Sabbah, Ahmed, et al.
Publicado: (2009) -
Innate Intracellular Antiviral Responses Restrict the Amplification of Defective Virus Genomes of Parainfluenza Virus 5
por: Wignall-Fleming, Elizabeth B., et al.
Publicado: (2020) -
Temporal Dynamics of the Ruminant Type I IFN-Induced Antiviral State against Homologous Parainfluenza Virus 3 Challenge In Vitro
por: Sun, Min, et al.
Publicado: (2022) -
Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3
por: Gaikwad, Swapnil, et al.
Publicado: (2013) -
Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
por: Scaggs Huang, Felicia, et al.
Publicado: (2020)